I will find it interesting at what point TIS start to re-include...

I will find it interesting at what point TIS start to re-include revenue projections in their investor presentation material. Im assuming this will be post approval and when sales start. They used to have modelled revenue growth which was compelling but dropped it over the last year presumably due to timing uncertanties of sales start point.

For any new holders refer back in old ASX announcements to the CEO presentation of November 2012 (page 11) which had the below sales revenue projections. Presuming you roll the start date forwards a year i can't see much in competitor landscape or effectivness of product which would change the below as a starting point for assumed growth profile.

Numbers from CEO presentation November 2012:
2013 - $0.44m
2014 - $22m
2015 - $71m
2016 - $209m
2017 - $358m
2018 - $460m
2019 - $675m

For longer term holders who have watched the story unfold over many years assuming approval goes to plan the money train could be about to leave the station. I for one won't be taking profits but holding till 2020.